UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005143
Receipt number R000006066
Scientific Title A Phase 2 study of Carboplatin plus Pemetrexed plus Bevacizumab as first-line therapy for stage3B/4 non-squamous non-small-cell lung cancer
Date of disclosure of the study information 2011/02/26
Last modified on 2014/09/02 13:49:26

No. Disposal Last modified on Item of update
1 Insert 2011/02/25 14:44:46
2 Update 2014/09/02 13:49:26 Email
Post marketing survey by drug manufacture etc., specified by Japanese law.